Management of bronchiectasis and chronic suppurative lung disease in Indigenous children and adults from rural and remote Australian communities

A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation.


The COPD National Program receives unrestricted sponsorship towards the development of training and resources from the following companies:


Foundation Partners:
Principal Partners:

Novartis Pharmaceuticals

AZ Logo 150px
Supporting Partners: GlaxoSmithKline.